249 related articles for article (PubMed ID: 35680956)
1. Lipase regulation of cellular fatty acid homeostasis as a Parkinson's disease therapeutic strategy.
Fanning S; Cirka H; Thies JL; Jeong J; Niemi SM; Yoon J; Ho GPH; Pacheco JA; Dettmer U; Liu L; Clish CB; Hodgetts KJ; Hutchinson JN; Muratore CR; Caldwell GA; Caldwell KA; Selkoe D
NPJ Parkinsons Dis; 2022 Jun; 8(1):74. PubMed ID: 35680956
[TBL] [Abstract][Full Text] [Related]
2. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment.
Fanning S; Haque A; Imberdis T; Baru V; Barrasa MI; Nuber S; Termine D; Ramalingam N; Ho GPH; Noble T; Sandoe J; Lou Y; Landgraf D; Freyzon Y; Newby G; Soldner F; Terry-Kantor E; Kim TE; Hofbauer HF; Becuwe M; Jaenisch R; Pincus D; Clish CB; Walther TC; Farese RV; Srinivasan S; Welte MA; Kohlwein SD; Dettmer U; Lindquist S; Selkoe D
Mol Cell; 2019 Mar; 73(5):1001-1014.e8. PubMed ID: 30527540
[TBL] [Abstract][Full Text] [Related]
3. Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase.
Imberdis T; Negri J; Ramalingam N; Terry-Kantor E; Ho GPH; Fanning S; Stirtz G; Kim TE; Levy OA; Young-Pearse TL; Selkoe D; Dettmer U
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20760-20769. PubMed ID: 31548371
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis.
Tripathi A; Alnakhala H; Terry-Kantor E; Newman A; Liu L; Imberdis T; Fanning S; Nuber S; Ramalingam N; Selkoe D; Dettmer U
J Neurosci; 2022 Mar; 42(10):2116-2130. PubMed ID: 35086904
[TBL] [Abstract][Full Text] [Related]
5. MUFA synthesis and stearoyl-CoA desaturase as a new pharmacological target for modulation of lipid and alpha-synuclein interaction against Parkinson's disease synucleinopathy.
Kula J; Kuter KZ
Neuropharmacology; 2024 May; 249():109865. PubMed ID: 38342377
[TBL] [Abstract][Full Text] [Related]
6. Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.
Nuber S; Zhang X; McCaffery TD; Moors TE; Adom MA; Hahn WN; Martin D; Ericsson M; Tripathi A; Dettmer U; Svenningsson P; Selkoe DJ
NPJ Parkinsons Dis; 2024 Feb; 10(1):47. PubMed ID: 38424059
[TBL] [Abstract][Full Text] [Related]
7. Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
Glajch KE; Moors TE; Chen Y; Bechade PA; Nam AY; Rajsombath MM; McCaffery TD; Dettmer U; Weihofen A; Hirst WD; Selkoe DJ; Nuber S
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326260
[TBL] [Abstract][Full Text] [Related]
8. Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor.
Terry-Kantor E; Tripathi A; Imberdis T; LaVoie ZM; Ho GPH; Selkoe D; Fanning S; Ramalingam N; Dettmer U
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707907
[TBL] [Abstract][Full Text] [Related]
9. A Stearoyl-Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α-Synuclein Mice.
Nuber S; Nam AY; Rajsombath MM; Cirka H; Hronowski X; Wang J; Hodgetts K; Kalinichenko LS; Müller CP; Lambrecht V; Winkler J; Weihofen A; Imberdis T; Dettmer U; Fanning S; Selkoe DJ
Ann Neurol; 2021 Jan; 89(1):74-90. PubMed ID: 32996158
[TBL] [Abstract][Full Text] [Related]
10. Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson's Disease.
Nuber S; Rajsombath M; Minakaki G; Winkler J; Müller CP; Ericsson M; Caldarone B; Dettmer U; Selkoe DJ
Neuron; 2018 Oct; 100(1):75-90.e5. PubMed ID: 30308173
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease: proteinopathy or lipidopathy?
Fanning S; Selkoe D; Dettmer U
NPJ Parkinsons Dis; 2020; 6():3. PubMed ID: 31909184
[TBL] [Abstract][Full Text] [Related]
12. Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.
Rajsombath MM; Nam AY; Ericsson M; Nuber S
J Neurosci; 2019 Sep; 39(38):7628-7640. PubMed ID: 31405930
[TBL] [Abstract][Full Text] [Related]
13. A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity.
Nuber S; Chung CY; Tardiff DF; Bechade PA; McCaffery TD; Shimanaka K; Choi J; Chang B; Raja W; Neves E; Burke C; Jiang X; Xu P; Khurana V; Dettmer U; Fanning S; Rhodes KJ; Selkoe DJ; Scannevin RH
Neurotherapeutics; 2022 Apr; 19(3):1018-1036. PubMed ID: 35445353
[TBL] [Abstract][Full Text] [Related]
14. Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons.
Fonseca-Ornelas L; Stricker JMS; Soriano-Cruz S; Weykopf B; Dettmer U; Muratore CR; Scherzer CR; Selkoe DJ
NPJ Parkinsons Dis; 2022 Sep; 8(1):118. PubMed ID: 36114228
[TBL] [Abstract][Full Text] [Related]
15. Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies.
Sharon R; Bar-Joseph I; Mirick GE; Serhan CN; Selkoe DJ
J Biol Chem; 2003 Dec; 278(50):49874-81. PubMed ID: 14507911
[TBL] [Abstract][Full Text] [Related]
16. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation.
Dettmer U; Newman AJ; Soldner F; Luth ES; Kim NC; von Saucken VE; Sanderson JB; Jaenisch R; Bartels T; Selkoe D
Nat Commun; 2015 Jun; 6():7314. PubMed ID: 26076669
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Cellular Palmitoylation Mitigates α-Synuclein Accumulation and Neurotoxicity.
Ho GPH; Ramalingam N; Imberdis T; Wilkie EC; Dettmer U; Selkoe DJ
Mov Disord; 2021 Feb; 36(2):348-359. PubMed ID: 33103814
[TBL] [Abstract][Full Text] [Related]
18. Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells.
Dettmer U; Ramalingam N; von Saucken VE; Kim TE; Newman AJ; Terry-Kantor E; Nuber S; Ericsson M; Fanning S; Bartels T; Lindquist S; Levy OA; Selkoe D
Hum Mol Genet; 2017 Sep; 26(18):3466-3481. PubMed ID: 28911198
[TBL] [Abstract][Full Text] [Related]
19. Vesicle trafficking and lipid metabolism in synucleinopathy.
Fanning S; Selkoe D; Dettmer U
Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605
[TBL] [Abstract][Full Text] [Related]
20. Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells.
Assayag K; Yakunin E; Loeb V; Selkoe DJ; Sharon R
Am J Pathol; 2007 Dec; 171(6):2000-11. PubMed ID: 18055555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]